Management and treatment of glomerular diseases (part 2): Conclusions From A Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Management and treatment of glomerular diseases (part 2): Conclusions From A Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference

Published:2021-01-21 Issue:1 Volume:25 Page:96-119
ISSN:2541-9439
Container-title:Nephrology (Saint-Petersburg)
language:
Short-container-title:Nefrologiâ (St.-Peterbg.)

Author:

Rovin Brad H.¹,Caster Dawn J.²,Cattran Daniel C.³,Gibson Keisha L.⁴,Hogan Jonathan J.⁵,Moeller Marcus J.⁶,Roccatello Dario⁷,Cheung Michael⁸,Wheeler David C.⁹,Winkelmayer Wolfgang C.¹⁰,Floege Jurgen¹¹

Affiliation:

1. The Ohio State University, Wexner Medical Center

2. University of Louisville School of Medicine

3. Toronto General Research Institute, University Health Network

4. University of North Carolina Kidney Center at Chapel Hill

5. University of Pennsylvania

6. Rheinisch-Westfalische Technische Hochschule, University of Aachen

7. University of Turin

8. KDIGO

9. University College London

10. Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine

11. Division of Nephrology

Publisher

Non-profit organization Nephrology

Subject

Nephrology

Reference190 articles.

1. Kidney Disease: Improving Global Outcomes (KDIGO) Glomerulonephritis Work Group. KDIGO clinical practice guideline for glomerulonephritis. Kidney Int Suppl 2012;2:139-274. doi: 10.1038/kisup.2012.12

2. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 1988; 8:85-89. doi: 10.1159/000167563

3. Vivarelli M, Massella L, Ruggiero B et al. Minimal change disease. Clin J Am Soc Nephrol 2017;12:332-345. doi: 10.2215/CJN.05000516

4. Rosenberg AZ, Kopp JB. Focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2017;12:502-517. doi: 10.2215/CJN.05960616

5. De Vriese AS, Sethi S, Nath KA et al. Differentiating primary, genetic, and secondary FSGS in adults: a clinicopathologic approach. J Am Soc Nephrol 2018;29:759-774. doi: 10.1681/ASN.2017090958

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human or Chimeric Monoclonal Anti-CD20 Antibodies for Children with Nephrotic Syndrome: A Superiority Randomized Trial;Journal of the American Society of Nephrology;2021-09-20

2. PLA2R1 and HLA-DQA1 gene variations in idiopathic membranous nephropathy in South China;Annals of the Academy of Medicine, Singapore;2021-01-31

3. Modern approaches to pharmacotherapy of chronic glomerulonephritis;Spravočnik vrača obŝej praktiki (Journal of Family Medicine);2020-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3